Ayşe Ceren Öztürk

Ayşe Ceren Öztürk

Auto-generated profile, based on publicly available information

Ayşe Ceren Öztürk

İZMİR BAKIRÇAY ÜNİVERSİTESİ, TIP FAKÜLTESİ

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 December 2025 in Kardiologiia
Verified
Journal Article
Closed access
ABAhmet Anıl BAŞKURT
Ahmet Anıl BAŞKURT
FYFerhat Siyamend Yurdam
Ferhat Siyamend Yurdam
SNSevinj Namazova
Sevinj Namazova
EBEREN OZAN BAKIR
EREN OZAN BAKIR
YDYusuf Demir
Yusuf Demir
OŞOktay şenöz
Oktay şenöz
Background   Cardioembolism in stroke and transient ischemic attack (TIA) patients is highly influenced by atrial fibrillation (AF). The best timing, duration, location (outpatient or inpatient), and procedure for diagnosing paroxysmal atrial fibrillation (PAF) after stroke / TIA are unknown. We investigated the use of smart devices in the detection of PAF during the index event hospitalization. Material and methods   Stroke and TIA patients hospitalized in the neurology service were evaluated. Patients with AF detected on the ECG at emergency department admission and patients with known AF were excluded from the study. Smartphone-based apps were given to 342 other patients to utilize the mobile app on smart devices during follow-up. Three cardiologists reviewed all smart device rhythm electrographs and identified patients with AF. On the basis of concurrent 24–72 h Holter rhythm monitoring, the patients were separated into those who had PAF (n=85; group 1) and those who did not have PAF (n=245; group 2). Results Left atrium size (LA), arterial hypertension, lowest and highest heart rate on the smart device and episodes of AF on the smart device differed between patients with and without PAFas noted on the 24–72 h Holter rhythm recordings. Detection of AF on the smart device was found to be an independent predictor of PAF as observed on the Holter rhythm recording (p=0.017). An AF episode identified on the smart device predicted the detection of PAF on the Holter 24–72 h rhythm recording with 58 % sensitivity and 87 % specificity. (AUC=0.723, 95 % CI=0.569–0.876, p=0.007) Conclusion The detection of PAF following acute ischemic stroke or TIA may be significantly improved during hospitalization by continuously monitoring cardiac rhythm with smart devices.

11 September 2026 in Anatolian Current Medical Journal
Verified
Journal Article
Open access
YAYıldız Arslan
Yıldız Arslan
AÖAyşe Ceren Öztürk
Ayşe Ceren Öztürk
BBBehice Bircan
Behice Bircan
YÇYeliz Çiftçi
Yeliz Çiftçi
BTBedile Irem Tiftikçioglu
Bedile Irem Tiftikçioglu
Aims: Diplopia is a common neuro-ophthalmological symptom with a wide etiological spectrum involving cranial nerves, the neuromuscular junction, extraocular muscles, and orbital structures. This study aimed to evaluate the clinical characteristics and etiological distribution of patients presenting with diplopia in a tertiary neurology setting.Methods: In this retrospective observational study, 55 patients evaluated for diplopia between January 2023 and August 2025 were analyzed. Demographic data, medical history, neurological and ophthalmological examination findings, laboratory results, neuroimaging, and electrophysiological studies were reviewed.Results: The mean age of the patients was 59±14.2 years, and 52.7% were female. Myasthenia gravis (MG) was the most common etiology (27.27%), followed by microvascular causes (20%) and idiopathic intracranial hypertension (IIH) (16.36%). Other causes included cerebrovascular diseases (14.54%), idiopathic cases (7.27%), multiple sclerosis (7.27%), and single cases of Miller–Fisher syndrome, intracerebral lymphoma, cavernous sinus thrombosis and pontin tumor (1.81% for each). Among the patient population, diabetes mellitus (DM) was diagnosed in 21 individuals and HT in 15. Thyroid function tests and C-reactive protein levels were within normal limits in all patients.Conclusion: The etiology of diplopia varies widely depending on clinical context and patient selection. In this cohort, MG was the leading cause, potentially reflecting referral patterns of a tertiary neurology center, where the diagnostic value and feasibility of single-fiber EMG were prominently demonstrated. The high prevalence of DM highlights diplopia as a potential early indicator of underlying metabolic dysfunction. Early diagnosis and targeted management are essential to improve clinical outcomes.